135 related articles for article (PubMed ID: 38245927)
1. Structural basis for T cell immunoglobulin and mucin protein 3 and Toxascaris leonina galectin complex.
Han CW; Jeong MS; Lee HN; Hwang EY; Jang SB
Biochem Biophys Res Commun; 2024 Feb; 697():149544. PubMed ID: 38245927
[TBL] [Abstract][Full Text] [Related]
2. Structure of full-length Toxascaris leonina galectin with two carbohydrate-recognition domains.
Jeong MS; Hwang HG; Yu HS; Jang SB
Acta Crystallogr D Biol Crystallogr; 2013 Feb; 69(Pt 2):168-75. PubMed ID: 23385453
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis for Carbohydrate Recognition and Anti-inflammatory Modulation by Gastrointestinal Nematode Parasite Toxascaris leonina Galectin.
Hwang EY; Jeong MS; Park SK; Ha SC; Yu HS; Jang SB
J Biol Chem; 2016 Dec; 291(49):25326-25338. PubMed ID: 27742836
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dextran sulfate sodium (DSS)-induced intestinal inflammation via enhanced IL-10 and TGF-beta production by galectin-9 homologues isolated from intestinal parasites.
Kim JY; Cho MK; Choi SH; Lee KH; Ahn SC; Kim DH; Yu HS
Mol Biochem Parasitol; 2010 Nov; 174(1):53-61. PubMed ID: 20603157
[TBL] [Abstract][Full Text] [Related]
5. Galectin-9 contributes to the pathogenesis of atopic dermatitis
Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q
Front Immunol; 2022; 13():952338. PubMed ID: 35967337
[TBL] [Abstract][Full Text] [Related]
6. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H
Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414
[TBL] [Abstract][Full Text] [Related]
7. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
[TBL] [Abstract][Full Text] [Related]
9. Galectin-9 regulates T helper cell function independently of Tim-3.
Su EW; Bi S; Kane LP
Glycobiology; 2011 Oct; 21(10):1258-65. PubMed ID: 21187321
[TBL] [Abstract][Full Text] [Related]
10. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
11. Galectin-9 and Tim-3 are upregulated in response to microglial activation induced by the peptide Amyloid-β (25-35).
Ramírez Hernández E; Hernández Zimbrón LF; Segura Pérez E; Sánchez Salgado JL; Pereyra Morales MA; Zenteno E
Neuropeptides; 2024 Jun; 105():102426. PubMed ID: 38527407
[TBL] [Abstract][Full Text] [Related]
12. Soluble T cell immunoglobulin mucin domain 3 (sTim-3) in maternal sera: a potential contributor to immune regulation during pregnancy.
Grossman TB; Minis E; Loeb-Zeitlin SE; Bongiovanni AM; Witkin SS
J Matern Fetal Neonatal Med; 2021 Dec; 34(24):4119-4122. PubMed ID: 32019363
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.
Sehrawat S; Reddy PB; Rajasagi N; Suryawanshi A; Hirashima M; Rouse BT
PLoS Pathog; 2010 May; 6(5):e1000882. PubMed ID: 20463811
[TBL] [Abstract][Full Text] [Related]
14. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection.
Elahi S; Niki T; Hirashima M; Horton H
Blood; 2012 May; 119(18):4192-204. PubMed ID: 22438246
[TBL] [Abstract][Full Text] [Related]
15. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.
Veenstra RG; Taylor PA; Zhou Q; Panoskaltsis-Mortari A; Hirashima M; Flynn R; Liu D; Anderson AC; Strom TB; Kuchroo VK; Blazar BR
Blood; 2012 Jul; 120(3):682-90. PubMed ID: 22677125
[TBL] [Abstract][Full Text] [Related]
16. Galectin-9 Alleviates LPS-Induced Preeclampsia-Like Impairment in Rats via Switching Decidual Macrophage Polarization to M2 Subtype.
Li ZH; Wang LL; Liu H; Muyayalo KP; Huang XB; Mor G; Liao AH
Front Immunol; 2018; 9():3142. PubMed ID: 30687334
[TBL] [Abstract][Full Text] [Related]
17. Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis.
Huang P; Lv C; Zhang C; Feng H; Li C; Zhang H; Zhao X; Li M
Gynecol Endocrinol; 2020 Jul; 36(7):605-610. PubMed ID: 32319832
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy.
Meggyes M; Miko E; Polgar B; Bogar B; Farkas B; Illes Z; Szereday L
PLoS One; 2014; 9(3):e92371. PubMed ID: 24651720
[TBL] [Abstract][Full Text] [Related]
19. Impact of Galectin-Receptor Interactions on Liver Pathology During the Erythrocytic Stage of
Wu Y; Huang S; Xiao S; He J; Lu F
Front Immunol; 2021; 12():758052. PubMed ID: 34899708
[TBL] [Abstract][Full Text] [Related]
20. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
